Innovation Pharmaceuticals Inc.

CIK 1355250 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Innovation Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Feb 1, 20248-K0001477932-24-000494
Dec 5, 20238-K0001477932-23-008988
Nov 20, 202310-Q0001477932-23-008688
Nov 15, 2023NT 10-Q0001477932-23-008500
Oct 30, 20238-K0001477932-23-007971
Sep 28, 202310-K0001477932-23-007158
May 15, 202310-Q0001477932-23-003414
Feb 15, 2023NT 10-Q0001477932-23-001052
Feb 15, 202310-Q0001477932-23-001071
Jan 4, 20238-K0001477932-23-000090
Jan 4, 202340001477932-23-000086
Nov 10, 202210-Q0001477932-22-008313
Sep 28, 202240001477932-22-007274
Sep 28, 202240001477932-22-007268
Sep 28, 202240001477932-22-007272
Sep 28, 202210-K0001477932-22-007292
Sep 28, 202240001477932-22-007270
Jul 5, 2022SC 13G/A0001213900-22-037187
Jun 15, 20228-K0001477932-22-004401
May 13, 202210-Q0001477932-22-003285
Feb 14, 202210-Q0001477932-22-000779
Nov 9, 202110-Q0001477932-21-007937
Oct 14, 20218-K0001477932-21-007301
Sep 27, 202110-K0001477932-21-006717
May 13, 202110-Q0001477932-21-003093